Top Markets
Coin of the day
Ulisse Biomed S.p.A. Ulisse Biomed S.p.A.

Ulisse Biomed S.p.A.

UBM
Rankning i aktier #29599
Ulisse Biomed S.p.A. is an Italy-based biotechnology enterprise specializing in... Ulisse Biomed S.p.A. is an Italy-based biotechnology enterprise specializing in healthcare diagnostics. The company develops and markets a diverse range of innovative platforms and products designed for disease detection. Central to its offerings is the Sagitta platform, which encompasses specialized tests such as Ladymed/HPV Selfy for human papillomavirus screening, CoronaMelt for identifying SARS-CoV-2, and CoronaMelt Var for detecting and genotyping SARS-CoV-2 variants. Sagitta also provides UlisseFaster, a vital reagent used for the pre-treatment of biological samples, alongside various diagnostic tools for sexually transmitted infections and for detecting HPV associated with oropharyngeal cancers. Beyond Sagitta, Ulisse Biomed boasts the NanoHybrid platform, an advanced multi-modal biomolecule system that utilizes DNA/PNA technology to directly identify specific antibodies and protein analytes from serum or whole blood samples. Its portfolio is further enhanced by the Aptavir platform, dedicated to the development and manufacturing of synthetic nucleic acid molecules aimed at curtailing the infectiousness of pathogens. Established in 2015, Ulisse Biomed S.p.A. operates from its headquarters in Udine, Italy.
Aktiekurs
$0.93739396
Senast synkroniserad: 2026-01-08
Marknadsvärde
$20.44M
Förändring (1 dag)
0.60%
Förändring (1 år)
-6.88%
Land
IT
Handel Ulisse Biomed S.p.A. (UBM)

Kategori

Aktiekurshistorik för Ulisse Biomed S.p.A. (UBM)
Högsta slutkurs: $0.94 den 2026-01-01

Lägsta slutkurs: $6.72 den 2021-08-01
Aktiekurshistorik för Ulisse Biomed S.p.A. från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 14.85%
2025 13.59%
2024 -56.85%
2023 70.06%
2022 -71.69%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$749.90 8.10%
CH
$1.07K -5.58%
KR